Home/Filings/4/0001127602-22-013350
4//SEC Filing

Louie Linda H. 4

Accession 0001127602-22-013350

CIK 0000318154other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 8:02 PM ET

Size

9.6 KB

Accession

0001127602-22-013350

Insider Transaction Report

Form 4
Period: 2022-05-02
Louie Linda H.
VP, Finance & CAO
Transactions
  • Award

    Nqso (Right to Buy)

    2022-05-02+3,5353,535 total
    Exercise: $230.92From: 2024-05-02Exp: 2032-05-02Common Stock (3,535 underlying)
  • Award

    Common Stock

    2022-05-02+4339,437 total
  • Tax Payment

    Common Stock

    2022-05-03$230.92/sh18$4,1579,419 total
Footnotes (4)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/2/2024, 5/2/2025 and 5/2/2026, respectively.
  • [F2]These shares include the following RSUs granted under the Company's equity plans: 67 RSUs which vest in an installment of 67 on 5/3/2023; 169 RSUs which vest in installments of 55 on 5/5/2022, 56 on 5/5/2023 and 58 on 5/5/2024; 1,453 RSUs which vest in two installments of 479 on 11/2/2022 and 11/2/2023 and one installment of 495 on 11/2/2024; 300 RSUs which vest in two installments of 99 on 4/30/2023 and 4/30/2024 and one installment of 102 on 4/30/2025; 350 RSUs which will vest in two installments of 175 on 11/5/2022 and 11/5/2023; and 433 RSUs which will vest in installments of 142 on 5/2/2024, 143 on 5/2/2025, and 148 on 5/5/2026.. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F3]These shares include 102 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
  • [F4]These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/2/2024, 5/2/2025 and 5/2/2026, respectively.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001818953

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 8:02 PM ET
Size
9.6 KB